A Palakkad court issued a non-bailable warrant against Baba Ramdev in a case filed by the Drugs Inspector. The case, registered in October 2024, falls under the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954. It alleges violations related to misleading medical claims. The court’s order highlights legal action against unverified health advertisements.
The Judicial First Class Magistrate II in Palakkad issued a non-bailable arrest warrant for yoga guru Baba Ramdev, his aide Acharya Balkrishna, and Divya Pharmacy, the marketing arm of their Haridwar-based Patanjali Ayurved, in connection with a misleading advertisements case.
Previously, the court issued a bailable warrant requiring their appearance on February 1.
However, since they did not appear, a non-bailable warrant was subsequently issued.
The next hearing is scheduled for February 15.
Also Read: Kerala Court Issues Arrest Warrant Against Baba Ramdev For Misleading Patanjali Ads
The same court had summoned them to appear on January 16, and their failure to comply resulted in the bailable warrant.
The case was filed by the Drugs Inspector of Palakkad in October 2024 under the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954. It concerns misleading advertisements in the media that falsely claimed Patanjali products could cure high blood pressure and diabetes.
Similar cases are also pending in Kozhikode and Haridwar, with multiple summons already issued.
Baba Ramdev is an Indian yoga guru, businessman, and co-founder of Patanjali Ayurved, a company known for Ayurvedic products and consumer goods. He gained widespread popularity through his yoga camps and television programs promoting yoga, Ayurveda, and natural health remedies.
Over the years, he has been involved in controversies, including legal issues related to misleading health claims and advertisements. His influence extends into politics, where he has openly supported various government policies. Despite legal challenges, Baba Ramdev remains a prominent figure in India’s wellness industry and continues to advocate for traditional Indian medicine and yoga practices.
Baba Ramdev has been involved in several controversies over the years, ranging from legal issues to political disputes. Here are some major controversies:
1. Misleading Health Claims & Legal Cases
- Non-Bailable Warrant (2024): A Palakkad court issued a non-bailable warrant against Baba Ramdev under the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954, for allegedly making misleading medical claims.
- COVID-19 Cure Claim (2020): Claimed Patanjali’s Coronil was a cure for COVID-19, leading to legal action and government intervention.
- Allopathy Remarks (2021): Faced backlash from doctors and medical associations for calling modern medicine “stupid science” and mocking allopathic treatments.
2. Patanjali’s Product Controversies
- Banned Products: Several Patanjali products, including medicines and food items, were flagged for quality issues.
- Mislabeling & False Advertising: Accused of making unverified claims about Patanjali products being more effective than established medicines.
3. Political Controversies
- Anti-Corruption Movement (2011-2012): Actively supported Anna Hazare’s anti-corruption protests and later aligned with the BJP.
- 2012 Midnight Crackdown: During a protest against black money in Delhi’s Ramlila Maidan, police evicted him and his supporters; Ramdev allegedly tried to escape in disguise.
4. Land & Business Disputes
- Illegal Land Acquisition: Faced allegations of acquiring land in Uttarakhand and other states at concessional rates for Patanjali.
- Encroachment Cases: Accused of encroaching on forest land and violating environmental laws.
5. Religious & Social Statements
- Beef Ban & LGBTQ+ Remarks: Advocated for a beef ban and made controversial statements against LGBTQ+ rights, suggesting yoga could “cure” homosexuality.
Despite these controversies, Baba Ramdev remains a significant figure in India’s yoga, Ayurveda, and business sectors.
FOLLOW US ON YOUTUBE FOR MORE LEGAL UPDATES
